Jump To
Innovation in Women's Health
Key takeaways
Drawing from SVB's proprietary data and insights and interviews with prominent investors and founders, our 2026 Innovation in Women's Health report examines trends across the venture-backed women's health sector, which has expanded well beyond reproductive and sexual health to address the full spectrum of women's health needs. Now a proving ground for the future of medicine, the sector is pioneering advances in integrated care, personalization and technology that are setting new standards of care for all patients.
$2B
VC invested in women's health across the US and Europe in 2025.
While this marked a dip from the 2024 peak, projections show a rebound in both deal volume and total women's health funding for 2026.
$6.2B
VC invested since 2019 in companies addressing conditions unique to women.
Plus 210 new startups dedicated to solving women-specific health challenges have launched in the same timeframe.
35M
Median pre-money valuation for AI-enabled women's health companies.
Startups using AI to personalize care are commanding valuations triple those of their non-AI counterparts.
The data
Our data unpacks the numbers behind the women's health opportunity, from the $2B invested in 2025 to the soaring valuations for AI-driven companies. We pinpoint where funding aligns with need and where the largest gaps remain across all women's health needs.
A 2025 dip gives way to a stronger 2026
US women's health VC saw a $1.2B pullback in 2025, but early indications suggest a rebound in 2026 as a new wave of seed and Series A companies prepares to emerge.
The dip reflects the sector's focus on therapeutics and care delivery, making it less susceptible to the AI investment hype in 2024 that inflated other healthcare verticals—and setting the stage for more stable, long-term growth.
Investors triple down on women's health AI
Valuations for AI-powered women's health companies were nearly 3x the sector median, a sharp departure from prior years when little difference existed between them.
Women's health AI investment is concentrated in clinical tools that predict and prevent costly health events like hospitalization and serious illness, rather than the drug discovery and operations focus in broader healthcare AI.
Investment aligns with shared disease burden
Diseases with high patient populations and low investment tend to attract VC funding. As a result, major women's health concerns tend to attract more money if they impact men as well.
This focus means women's health companies are helping to prove the value of personalized and precision medicine in a broader set of conditions that affect a variety of patients.
Explore other reports
Reports
The Future of Healthtech 2026
Nov 09, 2026
Megan Scheffel, Adam Tweedy, Dennis He, Matt Donne, Alex Lennox-Miller, Urbashee Paul, Josh Pherigo
Reports
The Future of Fintech 2026
Oct 13, 2026
Nick Christian, Brian Foley, Julie Wagne, Sophie McNaught, Josh Pherigo, Eli Oftedal, Andrew Pardo
Reports
The Future of Climate Tech
Apr 15, 2026
Jordan Kanis, Eli Oftedal, Josh Pherigo, Andrew Pardo